Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Oncology|January 27, 2009
Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancerHendrik-Tobias Arkenau, Andre T Brunetto, Jorge Barriuso, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSGViktor Grünwald, Saskia Litière, Robin Young, et al.
Clinical Sarcoma Research|November 28, 2013
Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literatureHan Hsi Wong, Helen M Hatcher, Charlotte Benson, et al.
Anticancer Research|October 28, 2015
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective StudyJonathan Noujaim, Khin Thway, Robin L Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2008
90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?Hendrik-Tobias Arkenau, David Olmos, Joo Ern Ang, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsRobin L Jones, David Olmos, Khin Thway, et al.
Anticancer Research|July 2, 2014
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experienceCharlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo, et al.
World Journal of Gastroenterology|April 21, 2015
Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgerySusan Lapthorne, Julie E Bines, Fiona Fouhy, et al.
Investigational New Drugs|October 8, 2010
Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumorsLaura Vidal, Margarita Magem, Clare Barlow, et al.
Pageof 16